Can You Change HCG Dosing for Fertility? (TRT Q&As)
Timeline
Dr. O’Connor discusses stopping testosterone while attempting to restore fertility and using HCG to stimulate testicular function. Because the available pen creates significant medication waste, he discusses the practical issue of transferring the medication to a sterile multi-use vial while emphasizing sterility and proper handling.
Dr. O’Connor explains that intramuscular and subcutaneous testosterone can have different absorption characteristics because of differences in blood supply. He also questions whether daily injections are necessary and discusses every-other-day dosing as a potentially simpler, more sustainable approach.
Dr. O’Connor questions treating an isolated positive H. pylori breath test without considering symptoms and the broader gastrointestinal picture. He recommends evaluation by a gastroenterology specialist to determine whether further testing and eradication treatment are actually appropriate.
Dr. O’Connor says there is no need to prolong testosterone when the goal is fertility restoration. He explains that testosterone can be stopped as HCG is started and that the long half-life of injectable testosterone means an elaborate taper or overlap is generally unnecessary.
The member is taking about 300 mg of testosterone weekly and asks about adding nandrolone after reading that lower doses may improve joint symptoms. Dr. O’Connor discusses the limited clinical evidence for using Deca specifically for joint health and cautions about cardiovascular, blood pressure, fluid retention, and other risks associated with adding another androgen.
After learning that the member is also taking anastrozole for elevated estradiol, the discussion turns to whether suppressing estrogen may be contributing to his joint symptoms. Dr. O’Connor and the clinicians favor minimizing unnecessary aromatase inhibitor use and emphasize treating the individual rather than automatically suppressing estradiol.
Video Summary
This episode focuses on refining testosterone therapy decisions through careful interpretation of symptoms and laboratory data. It explains how progress should be evaluated across trends rather than isolated results. Hormone care is framed as structured clinical management.
A central segment discusses cholesterol, hematocrit, and hormone levels within the broader context of patient health. It emphasizes avoiding fear-driven reactions to individual lab markers. Balanced interpretation is reinforced as essential.
The closing portion reinforces testosterone therapy as long-term medical care. Monitoring, patience, and informed participation are emphasized. Hormone management is positioned as a process supported by follow-up and education.
Drug Callouts
Condition Callouts
Key Takeaways
- Trends provide more insight than isolated lab values.
- Balanced interpretation reduces unnecessary therapy changes.
- Cholesterol and hematocrit require context.
- Symptoms should be assessed longitudinally.
- Monitoring supports safe long-term hormone care.